HealthcareServices

Global Biopharmaceutical CMO And CRO Market Report 2026–2035: Key Forecasts and Growth Areas

February 20, 2026February 20, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the biopharmaceutical cmo and cro market from 2026–2035 with trusted insights from The Business Research Company

How is the Biopharmaceutical CMO And CRO Market size predicted to change over the forecast window of 2026–2035?

The biopharmaceutical cmo and cro market size has shown significant expansion in recent years. This market is anticipated to expand from $35.6 billion in 2025 to $38.01 billion in 2026, achieving a compound annual growth rate (CAGR) of 6.8%. Historically, the market’s growth can be ascribed to several factors, including the increasing complexity of biologic drug development, rising R&D costs for biopharmaceutical companies, the expansion of clinical trial activities, the growth in biosimilar development, and the availability of specialized contract service providers.

The biopharmaceutical cmo and cro market is projected to experience robust expansion over the coming years. This market is anticipated to reach $48.79 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.4%. This expansion during the projected timeframe is driven by factors such as a heightened need for sophisticated biologics production, increased funding in cell and gene therapies, an expanding global portfolio of clinical trials, a greater emphasis on strategies for faster market entry, and the wider integration of digital CRO solutions. Key developments foreseen within this period encompass a rise in outsourcing for biologic drug production, a surging need for comprehensive contract research offerings, an increased priority on adaptive manufacturing capabilities, broadening support for cell and gene therapy advancements, and a stronger focus on services ensuring regulatory adherence.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=19337&type=smp

Which Drivers Are Contributing To The Expansion Of The Biopharmaceutical CMO And CRO Market?

Increased spending on research and development is anticipated to fuel the expansion of the biopharmaceutical CMO and CRO market in the future. This rise in R&D funding is attributed to various factors, including the imperative for innovation, competitive pressures, the necessity to meet evolving market requirements, and governmental support. Such investments empower CMOs and CROs to develop superior manufacturing techniques and research protocols, consequently boosting their capabilities and operational effectiveness. This commitment to innovation attracts and retains clientele by offering advanced solutions while ensuring adherence to regulatory standards. For example, as reported by Eurostat, the Luxembourg-based statistical agency, in September 2025, the European Union allocated approximately $456 billion USD (€389 billion) to research and development (R&D) in 2023, with R&D spending as a percentage of GDP increasing to 2.26% from 2.22% the year before. Consequently, the escalating investment in research and development is a key catalyst for the growth of the biopharmaceutical CMO and CRO market.

What Segment Categories Are Covered In The Biopharmaceutical CMO And CRO Market?

The biopharmaceutical cmo and cro market covered in this report is segmented –

1) By Product: Biologics, Biosimilars

2) By Service Type: Contract Manufacturing, Contract Research

3) By Source: Mammalian, Non-Mammalian

Subsegments:

1) By Biologics: Monoclonal Antibodies (mAbs), Vaccines, Recombinant Proteins, Cell and Gene Therapies, Antibody-Drug Conjugates (ADCs), Therapeutic Enzymes

2) By Biosimilars: Biosimilar Monoclonal Antibodies, Biosimilar Insulins, Biosimilar Growth Hormones, Biosimilar Erythropoietins, Biosimilar Granulocyte Colony-Stimulating Factors (G-CSFs)

Which Trends Are Influencing The Development Of The Biopharmaceutical CMO And CRO Market?

Leading companies in the biopharmaceutical CMO and CRO market are initiating strategic partnerships with the goal of improving services, increasing efficiencies, and speeding up drug development for biopharmaceutical businesses. Strategic partnerships involve companies leveraging their respective strengths and resources to achieve mutual advantages and success. For example, in June 2024, Abzena plc., a biopharmaceutical company based in the UK, collaborated with Argonaut Manufacturing Services Inc., a US-based contract manufacturing organization (CMO), to combine drug development and manufacturing solutions for their customers. Through this partnership, they intend to offer accelerated, complete drug development and manufacturing solutions that enhance efficiency, decrease costs, and streamline biopharmaceutical production for clients.

Which Key Players Are Driving Competition In The Biopharmaceutical CMO And CRO Market?

Major companies operating in the biopharmaceutical cmo and cro market are Thermo Fisher Scientific Inc., Boehringer Ingelheim International GmbH, Eurofins Scientific SE, Lonza Group AG, Syneos Health Inc., Catalent Inc., Charles River Laboratories International Inc., Parexel International (MA) Corporation, Samsung Biologics Co. Ltd., CELLTRION INC., Medpace Holdings Inc., Fujifilm Diosynth Biotechnologies UK Limited, Almac Group, Pharmaron Beijing Co. Ltd., Worldwide Clinical Trials, KBI Biopharma, Inotiv Inc., Caidya, Rentschler Biopharma SE, Celerion Inc., TFS HEALTHCARE LIMITED

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-cmo-and-cro-global-market-report

Which Region Is Projected To Lead The Biopharmaceutical CMO And CRO Market During The Forecast Period?

North America was the largest region in the biopharmaceutical CMO and CRO market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biopharmaceutical cmo and cro market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biopharmaceutical CMO And CRO Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=19337&type=smp

Browse Through More Reports Similar to the Global Biopharmaceutical CMO And CRO Market 2026, By The Business Research Company

Biopharmaceutical Third Party Logistics Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopharmaceutical-third-party-logistics-global-market-report

Biopharmaceuticals Contract Manufacturing Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopharmaceuticals-contract-manufacturing-global-market-report

Lyophilization Services For Biopharmaceuticals Market Report 2026

https://www.thebusinessresearchcompany.com/report/lyophilization-services-for-biopharmaceuticals-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795